-
Loading metrics
Open Access
Peer-reviewed
Research Article
Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease
-
Erin Hertlein,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Kyle A. Beckwith,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Gerard Lozanski,
Affiliation Department of Pathology, the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Timothy L. Chen,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
William H. Towns,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Amy J. Johnson,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Amy Lehman,
Affiliation Center for Biostatistics, the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Amy S. Ruppert,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Brad Bolon,
Affiliation Department of Veterinary Biosciences and the Comparative Pathology and Mouse Phenotyping Shared Resource, the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Leslie Andritsos,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Arletta Lozanski,
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ -
Laura Rassenti,
Affiliation Moores University of California-San Diego Cancer Center, University of California San Diego, California, United States of America
⨯ -
Weiqiang Zhao,
Affiliation Department of Pathology, the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Tiina M. Jarvinen,
Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Leigha Senter,
Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Carlo M. Croce,
Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at the Ohio State University, Columbus, Ohio, United States of America
⨯ -
David E. Symer,
Affiliations Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America, Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Albert de la Chapelle,
Affiliation Department of Molecular Virology, Immunology and Medical Genetics, Division of Human Cancer Genetics, Comprehensive Cancer Center at the Ohio State University, Columbus, Ohio, United States of America
⨯ -
Nyla A. Heerema,
Affiliation Department of Pathology, the Ohio State University, Columbus, Ohio, United States of America
⨯ - [ ... ],
-
John C. Byrd
* Email: john.byrd@osumc.edu
Affiliation Department of Internal Medicine, Division of Hematology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, United States of America
⨯ - [ view all ]
- [ view less ]
Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease
- Erin Hertlein,
- Kyle A. Beckwith,
- Gerard Lozanski,
- Timothy L. Chen,
- William H. Towns,
- Amy J. Johnson,
- Amy Lehman,
- Amy S. Ruppert,
- Brad Bolon,
- Leslie Andritsos
- Published: October 9, 2013
- https://doi.org/10.1371/journal.pone.0076607